The stage-dependent phagocytosis of Plasmodium falciparum-infected erythrocytes (IRBC) opsonized with nonimmune serum has been investigated. An average of 2.9 red blood cell (RBC) harboring ring-forms (RIRBC) and 7.5 RBC infected with trophozoites (TIRBC) or schizonts (SIRBC) were ingested per monocyte, in comparison with 0.8 noninfected RBC (NRBC) In vitro, IRBC are phagocytosed by cultured ma~rophages.4-~ These observations imply that IRBC can be removed in the absence of specific immunity of the host. Several investigators have recently outlined a removal model to explain phagocytosis of senescent and oxidatively damaged RBC.8-13 In this model, modifications of band 3 and deposition of anti-band 3 antibodies are considered to be the first in a series of events, eventually leading to activation of alternative complement pathway and C3b deposition on the RBC.11-13 C3b-coated RBC are recognized by macrophage complement receptor type 1 (CRl, CD3514) and phagocytosed. Complement receptor type 3 (CR3), which reacts with iC3b and C3d15 was found to play no significant role in removal of senescent human RBC.16 The proposed removal m0de1ll-l~ does not exclude binding of other naturally occurring antibodies,17J8 or exposure of other removal marker~.l~-~l The membrane of IRBC is profoundly altered and parasite-produced antigens are inserted in the host RBC membrane.22,23 Phospholipid flip-flop is accelerated and phosphatidylserine (PS) appears at the exofacial side," although this has been c o n t e~t e d .~~-~~ Most importantly, the parasite exerts a considerable oxidative offensive on its host RBC28,29 that could eventually lead to similar alterations as those seen in oxidatively damaged normal RBC. Thus, prima facie, IRBC are prone to be phagocytosed by macrophages as nonself cells. However, the details of the IRBC and macrophage components involved in this process have not been investigated.
N NONIMMUNE Plasmodium falcipamm malaria pa-I tients, circulating and resident macrophages are commonly seen loaded with infected red blood cells (IRBC) or malarial
In vitro, IRBC are phagocytosed by cultured ma~rophages.4-~ These observations imply that IRBC can be removed in the absence of specific immunity of the host. Several investigators have recently outlined a removal model to explain phagocytosis of senescent and oxidatively damaged RBC.8-13 In this model, modifications of band 3 and deposition of anti-band 3 antibodies are considered to be the first in a series of events, eventually leading to activation of alternative complement pathway and C3b deposition on the RBC.11-13 C3b-coated RBC are recognized by macrophage complement receptor type 1 (CRl, CD3514) and phagocytosed. Complement receptor type 3 (CR3), which reacts with iC3b and C3d15 was found to play no significant role in removal of senescent human RBC. 16 The proposed removal m0de1ll-l~ does not exclude binding of other naturally occurring antibodies,17J8 or exposure of other removal marker~.l~-~l The membrane of IRBC is profoundly altered and parasite-produced antigens are inserted in the host RBC membrane.22,23 Phospholipid flip-flop is accelerated and phosphatidylserine (PS) appears at the exofacial side," although this has been c o n t e~t e d .~~-~~ Most importantly, the parasite exerts a considerable oxidative offensive on its host RBC28,29 that could eventually lead to similar alterations as those seen in oxidatively damaged normal RBC. Thus, prima facie, IRBC are prone to be phagocytosed by macrophages as nonself cells. However, the details of the IRBC and macrophage components involved in this process have not been investigated.
The present study of phagocytosis of IRBC opsonized with nonimmune serum is an attempt to simulate events occurring in naive patients during first infection. By far the largest number of deaths caused by malaria occurs in young children as the consequence of a first malaria episode, whereby acute anemia outnumbers cerebral malaria in some areas as the cause of deathPo The capacity of the host phagocytes to recognize and remove IRBC efficiently constitutes the principal line of defense in those nonimmune ment, non-lgG-, and non-PS-dependent phagocytosis amounted t o 6% t o 18% of total phagocytosis in RIRBC and TIRBC, respectively. RIRBC bound 2.5 times more protein A and 3.1 times more anti-C3c (a stable derivative of C3b) antibodies, and TlRBC bound 20 times more protein A and 6.8 times more anti-C3c antibodies than NRBC. Phagocytosis of oxidatively damaged RBC and RIRBC are similar, whereas a higher portion of phagocytosis appears t o be noncomplement-dependent and PS-suppressible in TIRBC. It is concluded that RIRBC generate recognition signals similar t o those present in oxidatively damaged or senescent RBC. Extensive membrane modifications in TlRBC produce additional, hitherto undefined signals that induce much higher and qualitatively distinct phagocytosis. 0 1992 by The American Society of Hematology.
patients. Moreover, IRBC-harboring mature parasite forms are toxic to the macrophage3I (and Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, Arese P: submitted) and most dangerous to the host, because they are responsible for cerebral malaria.32 For these reasons, it seemed of interest to dissect the stage-dependent recognition of IRBC as the first step in finding ways to enhance phagocytic removal of nontoxic early stages.
We show here that ring-infected RBC (RIRBC) are phagocytosed similarly to senescent or oxidatively damaged RBC, where deposition of immunoglobulin G (IgG) and complement produce recognition signals for phagocytosis. RBC infected with trophozoites (TIRBC) or schizonts (SIRBC) are phagocytosed more intensely, and exposed PS adds to the other recognition signals. A significant fraction of phagocytosis of late stages is mediated by recognition signals that could not be accounted for at the present time.
MATERIALS AND METHODS
FCR-3 strain of P falcipamm was cultivated as described previ0usly.3~ Fresh saline-washed O+ human RBC 802 TURRlNl ET AL were suspended (hematocrit: 0.2%) in RPMI 1640 culture medium (Flow Laboratories, McLean, VA), containing 10 mmol/L glucose, 24 mmol/L sodium bicarbonate, 25 mmol/L N-(2-hydroxyethyl)-piperazine-" (ethanesulfonic acid) (HEPES) (Sigma Chemical Co, St Louis, MO), pH 7.4, and supplemented with 10% heat (45 minutes at 56"C)-inactivated AB+ plasma. The RBC suspension was inoculated with parasite-infected cells at 1% to 2% initial parasitemia in culture flasks and gassed with a mixture of 90% Nz, 5% 0 2 , 5% C02. Cultivation was performed at 37°C with daily changes of medium and gassing.
Cultures were synchronized by the sorbitol using alanine instead of sorbitol (Sigma) because of its lower toxicity to the cells.
RBC infected with different stages of parasite maturation were isolated from nonsynchronized cultures by the Percoll (Sigma)-sorbitol method.34 Parasitemia was evaluated by microscopic inspection of Giemsa-stained thin blood smears. The ring-containing fraction usually had a parasitemia of 60% to 70%, and did not contain any other stages. The trophozoite fraction contained up to 5% RIRBC and no NRBC. The schizont fraction contained traces of free malarial pigment and did not contain any other stages. Cells were then washed three times in phosphate-buffered saline (PBS) containing 5 mmol/L glucose, pH 7.4 (PBSg) and treated as required.
Washed RBC were suspended (hematocrit: 33%) in PBSg supplemented with diamide (Sigma) (200 pmol/L final concentration) and incubated at 37°C for 60 minutes. Cells were then washed three times in PBSg and treated as required.
Washed RBC were incubated at 37°C for 30 minutes (hematocrit: 33%) in fresh human AB+ serum, in heatinactivated human AB+ serum (45 minutes at 56"C), or in diisopropylfluorophosphate (Sigma) (DFP)-treated serum diluted 1:l with PBSg.
Fresh human AB+ serum was incubated at 37°C for 15 minutes with DFP (4 mmol/L final concentration). DFP-treated serum was dialyzed overnight against 5,000 vol PBS at 4°C."
Opsonized RBC were washed three times in PBS and incubated at 37°C for 60 minutes (hematocrit: 10%) in PBSg containing 13 pg/mL affinitypurified F(ab')z fragment of a rabbit polyclonal antihuman Fc antibody (Jackson Immunoresearch Laboratories, West Grove, PA). RBC were then washed three times in PBS. The efficiency of antihuman Fc antibody in inhibiting purely Fc-mediated phagocytosis has been tested. Washed NRBC were incubated at 37°C for 60 minutes (hematocrit: 33%) in PBSg supplemented with 0.1, 1, or 10 pg/pL anti-D antibody (Dakopatts, Glostrup, Denmark). Treatment with 1 or 10 pg/mL anti-D maximized phagocytic susceptibility to 5.1 f 1 (n = 4) and 5.3 f 1.2 (n = 4) ingested RBC/ monocyte, respectively (phagocytosis of untreated controls was 0.7 2 0.14 [n = 41). RBC pretreated with 1 or 10 pg/mL anti-D antibody were washed three times in PBS and treated or not with antihuman Fc antibody as specified above. RBC were then washed three times in PBS and subjected to phagocytosis assay. Treatment with antihuman Fc antibodies inhibited phagocytosis of RBC pretreated with either 1 or 10 pg/mL anti-D by 91.4 f 3.9% (n = 4) and by 93 f 4.1% (n = 4), respectively.
Synchronized IRBC, grown for 36 hours up to the trophozoite stage in absence of plasma, were incubated at 4°C (to avoid complement activation) for 2 hours (hematocrit: 10%) with fresh AB+ serum. IRBC were then spun down and serum collected. The procedure was repeated again with a new batch of cells. This antibody-depleted serum was used as such or supplemented with 10 pg/mL (final concentration) affinity Fresh whole O+ human blood, anticoagulated with heparin, was fractionated on a Lymphoprep gradient.35 Separated lympho-monocytes suspended in RPMI 1640 supplemented with 10% (vol/vol) fetal calf serum (Flow), were plated in 24-wells Petri dishes (Flow). After 60 minutes incubation in a humidified incubator (air-5% COz atmosphere, 37"C), nonadherent cells were removed and monocytes were further incubated for 24 to 48 hours before initiation of phagocytosis experiments. Each well usually contained 50,000 to 70,000 monocytes in 1 mL of RPMI 1640 supplemented with 10% (vol/vol) fetal calf serum. Monocytes were quantified by a DNA microassay using bisbenzimide (Sigma) as fluorescent intercalating pr0be.3~
Five microliters of RBC washed twice and suspended in PBSg (hematocrit: 33%) were added to each well containing adherent monocytes to achieve a ratio of about 300 RBC per monocyte. After 60 minutes incubation in a humidified incubator (air-5% COz atmosphere, 37"C), nonadherenthoningested RBC were removed by aspiration and three washes with 1 mL PBS each. Noningested, adherent RBC were lysed by a 20-second treatment with distilled water, followed by an additional wash with 1 mL PBS. This treatment lyses completely adhering RBC but does not compromise the integrity of monocytes.35 Monocytes and the ingested parasite pigment were then dissolved in 1 mL NaOH 0.1 mol/L containing 0.05% (vol/vol) Triton X-100 (Biorad Laboratories, Richmond, CA). Phagocytosis was quantified by measuring the chemiluminescence of the heme (derived from host cell hemoglobin and parasite pigment) ingested by the macrophages after their interaction with RBC, taking advantage of the peroxidase activity of heme. The heme of ingested hemoglobin catalyzes the production of chemiluminescence by luminol (Sigma) and tert-butylhydroperoxide (Fluka, Buchs, Switzerland) at alkaline pH according to the reaction:
Monocyte separation and cultivation.
Phagocytosis assay.
Luminol + 2 tert-butylhydroperoxide + Aminophthalic Acid + N2 + 2 Butanol + Light
The amount of emitted light is proportional to the heme concentration. In our assay, chemiluminescence was elicited by injecting 100 p L of a tert-butylhydroperoxide/EDTA (Merck, Darmstadt, Germany) solution (containing 3.7 mmol/L tert-butylhydroperoxide and 3 mmol/L EDTA dissolved in 0.1 N NaOH). The injection of tert-butylhydroperoxide triggered photon emission and counting. Because light emission reached its maximum in less than 1 second and did not decrease until approximately 2.5 seconds, integrated photon counting time was set at 2 seconds. Photon counting was performed with a Ciba Coming Magic Lite Analyzer (Ciba Coming Diagnostic Corp, Redfield, MA). Photon counts per macrophage were transformed into RBC ingested per macrophage by comparison with a calibration curve run for each experiment with known amounts of cells out of the same sample used for that specific experiment. For example, in the case of phagocytosis of TIRBC, the calibration curve was performed using the same TIRBC suspension used for the experiment. The calibration experiments using noninfected RBC or IRBC harboring different stages of parasites, yielded essentially identical chemiluminescence versus number of cells, indicating that the total heme content per cell remains constant throughout parasite development. This is in accordance with the constancy of IRBC iron content during parasite m a t~r a t i o n .~~ Time-dependent analysis of luminescence elicited by monocytes kept in culture for 60 minutes after phagocytosis showed no decrease in luminescence, indicating that heme was not metabolized. Reagent luminescence and eigenlumines- minutes. Under these conditions, full saturation of IgG was achieved because higher concentrations of protein A or longer incubation did not result in higher RBC labeling (not shown). After incubation, the RBC suspension was diluted 1:lO with PBSg-BSA, layered on 20% Ficoll (Sigma), and spun down at 2,oaOg and 4°C for 15 minutes. The supernatant was carefully aspirated, RBC transferred to a fresh tube, washed once more with 4 mL PBSg-BSA, and the RBC-associated radioactivity counted. The number of (lZ5I) protein A molecules bound to the RBC surface was calculated according to radioactivity counts, protein A specific activity, and the RBC number, determined in a BiirkerTreatment of monocytes with anti-CR1 antibodies.
Binding of (1251)protein A. A second aliquot of 20 p,L washed and packed RBC was added to 50 pL PBSg-BSA supplemented with 85 pg (lZ1)goat antibody to human C3c (specific activity: 9.9 p,Ci/mg protein) and incubated at 37°C for 60 minutes. After incubation, the RBC suspension was processed as described above and the RBC-associated radioactivity counted. The anti-C3c antibody (affinity-purified polyclonal, The Binding Site, Birmingham, UK) was radioiodinated with 1251 (Amersham) by the iodobeads iodination reagent (Pierce, Rockford, IL).
Liposomes were prepared from phosphatidylcholine (PC) (Sigma) or a mixture of PC and PS (Sigma) as described elsewhere.21 A liposome suspension containing 100 pg phospholipid was added to each well containing 50,000 to 70,000 adherent monocytes 5 minutes before the RBC challenge. Phagocytosis assay was performed as described above.
Binding of (1251)anti-C3c antibodies.

Treatment of monocytes with liposomes.
RESULTS
Stage-dependence and opsonization-dependence ofphagogtosis. Nonsynchronous cultures of IRBC were fractionated to obtain NRBC, RIRBC, TIRBC, and SIRBC. Serum-opsonized IRBC were phagocytosed more intensely than NRBC and the extent of phagocytosis depended on the parasite maturation stage (Fig 1) . An average of 2.9 serum opsonized RIRBC and 7.5 TIRBC/SIRBC were phagocytosed per monocyte, compared with 0.8 NRBC or 5 Role of IgG in the phagoqtosis of IRBC. IgG-mediated phagocytosis was estimated by blocking the Fc portion of IgG bound to the RBC. This was achieved by treating fresh serum-opsonized RBC with the F(ab')z fragment of polyclonal antibodies against the Fc portion of human IgG. This treatment should abrogate IgG-mediated recognition and have no effect on complement-mediated recognition. As shown in Fig 3, phagocytosis decreased nonsignificantly by 14% in both RIRBC and TIRBC. On the other hand, when IRBC were first opsonized with DFP-treated serum and then Fc-blocked, both complement-and IgG-mediated phagocytosis should be abolished. In this case, phagocytosis was reduced by 83% in RIRBC and by only 61% in TIRBC. Therefore 17% of phagocytosis in RIRBC and 39% in TIRBC seems to be neither complement-mediated nor IgG-mediated.
Binding of (1251) diamide-treated, oxidatively damaged4143 RBC. Omission of opsonization with fresh serum vastly abrogated the increase in phagocytosis of RIRBC and diamide-treated RBC, but only reduced by 30% and 40% phagocytosis of TIRBC and SIRBC, respectively. To estimate the role of complement deposition in the phagocytosis of IRBC, opsonization of IRBC was performed with DFP-treated or heat-inactivated serum. Both treatments inactivate C3 convertase and block C3b production and d e p o~i t i o n .~~. 3~.~ Because heat inactivation of serum may partially aggregate IgG, and DFP treatment only inactivates alternative complement pathway, monocytes in which complement receptor type 1 (CR1, CD35) had been blocked by anti-CR1 monoclonal antibodies (MoAbs) were also used. As shown in Fig 2, opsonization with DFP-treated or heat-inactivated serum inhibited phagocytosis of RIRBC by 78% to 95%, of diamide-treated NRBC by 77% to loo%, and of TIRBC by only 37% to 50%, respectively. Blockage of CR1 extensively inhibited phagocytosis of RIRBC (-86%) and of diamide-treated NRBC (-95%), and much less that of TIRBC (-25%). SIRBC 
SERUM
IgG-DEPLETED SERUM T supplemented with anti-band 3, but not with antispectrin antibodies. Nonimmunological triggers have been described to play a role in recognition of altered RBC. These signals are caused by the exposure of phosphatidylethanolamine (PE) and PS on the RBC exoface and their recognition by putative receptors on the m o n~c y t e .~~,~~.~ To quantify the effect of PS-mediated recognition, PS liposomes were given to adherent monocytes 5 minutes before the RBC challenge. The effect of PS treatment was tested with RBC in which complement-and IgG-mediated recognition had been blocked (see Fig 3) . Results shown in Fig 6 indicate no effect with RIRBC, but a small, significant increase in phagocytosis inhibition (from 61% to 82% inhibition) with TIRBC. Parallel experiments with PC liposomes were without effect. The combined suppression of complement-, IgG-, and PS-dependent phagocytosis did not completely abrogate phagocytosis of IRBC. The residual, nonsuppressible phagocytosis amounted to 6% of total phagocytosis in RIRBC and to 18% in TIRBC.
Involvement of PS in thephagocytosis of ZRBC.
DISCUSSION
The present results show that IRBC opsonized with nonimmune serum are avidly phagocytosed by human monocyte-derived macrophages. This mechanism may provide the first line of defense against malaria infection in nonimmune individuals. We attempted to characterize the various components involved in the recognition of IRBC by the macrophage at the various stages of parasite development. Our results show that phagocytosis of IRBC remarkably increases with parasite maturation (Fig 1) . The progression parallels the increase in metabolic activity of the parasite and the resulting structural and functional alterations induced in the membrane of the host RBC. These alterations probably underly the increased binding of IgG and complement components to the surface of IRBC (Fig  4) . Increased binding of complement and IgG to RBC in malaria patients has been described$s47 suggesting that such binding may be important for the in vivo immune response. Present data show that TIRBC and SIRBC bind 8 times more IgG and about 2 times more complement components than RIRBC. Correspondingly, phagocytosis is extremely intense, and approximately an average of 2.5 as many TIRBC or SIRBC were ingested by each monocyte compared with diamide-treated RBC (see Fig l) , to glucose-6-phosphate dehydrogenase deficient RBC during the favic crisis,'@ to RBC isolated out of the 1% densest RBC fraction (Lutz HU, Turrini F, Arese P: submitted), or to sickled RBC. 49 Because anti-band 3 antibodies have been implicated in For personal use only. on October 3, 2017. by guest www.bloodjournal.org From the removal of senescent and oxidatively damaged RBC?-I3 an attempt has been made to establish their involvement in phagocytosis of IRJ3C. Indeed, incubation of IRBC with IgG-depleted serum resulted in partial inhibition of phagocytosis. Phagocytosis was restored by the addition of purified anti-band 3 antibodies to IgG-depleted serum. No restoration was observed with antispectrin antibodies (Fig  5) . Stepwise inhibition experiments show that complementmediated phagocytosis is more prominent in RIRBC than in TIRBC or SIRBC. Whereas the small, nonsignificant share of IgG-mediated phagocytosis (14% of total phagocytosis) is not modified, complement-mediated phagocytosis drops from 78% to 95% in RIRBC to 37% to 50% of total phagocytosis in TIRBC. It should be noted that the absolute amount of complement-dependent phagocytosis is slightly increased in TIRBC and SIRBC.
Therefore, the strong increase in overall phagocytosis in late stages is to be accounted for by new recognition signals that add to but do not replace markers present at the ring stage. One additional phagocytosis signal specific for later maturation stages is represented by PS appearing on the RBC exoface. Appearance of PS on the exoface of altered RBC and the putative PS receptor on the macrophages seems to play a role in the removal of sickled RBC.19,21*44 Although the flip-flop of PS is clearly enhanced in membranes of IRBC," the presence of PS in measurable quantities in the outer monolayer is a subject of controAlthough activation of prothrombinase resulting from exofacial PS on IRBC membranes could not be shown,25 phagocytosis of TIRBC (but not of RIRBC) was specifically inhibited by PS-containing liposomes, inasmuch as PC liposomes had no effect. These apparent discrepancies are possibly attributable to differences in the susceptibility of these processes to PS concentration. Interestingly, deoxygenated sickle cells display increased deposition of autologous IgG>9,50 increased phagocytosi~,4~,~~ and increased transbilayer movement of pho~phoIipids,5~.~~ but no prothrombinase activati0n.5~
In conclusion, it seems that phagocytosis of RIRBC mostly depends on deposition of complement components, in analogy with the removal mechanism found to be operative in oxidatively damaged RBC (see Fig l) , in very dense, biologically senescent RBC (Lutz HU, Turrini F, Arese P: submitted), and in pathologically altered RBC.48,49 RBC in which band 3 had been clustered by strongly cationic reagents are also phagocytosed via a predominantly complement-dependent recogniti0n.5~ Because the parasite produces histidine-rich proteins that are deposited at the cytoplasmic face of the host membrane in juxtaposition with band 3 aggregates," it may well be that perturbations induced in the band 3 distribution contribute to deposition of IgG and complement. At later developmental stages, phagocytosis is negotiated by more complex, possibly pleiotropic, removal markers. The ingestion of TIRBC and SIRBC is mediated by the concerted effect of complement and IgG deposition, as well as by the exposure of PS. At all stages of parasite development, a small but significant fraction of phagocytosis is mediated by markers that cannot be accounted for at the present time. 
